FMP
Qualigen Therapeutics, Inc.
QLGN
NASDAQ
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
3.9 USD
-0.06 (-1.54%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Kevin A. Richardson II
sector
Healthcare
industry
Biotechnology
website
https://www.qualigeninc.comexchange
NASDAQ
Description
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in...
CIK
0001460702
ISIN
US74754R2022
CUSIP
74754R103
Address
2042 Corte Del Nogal
Phone
760 918 9165
Country
US
Employee
4
IPO Date
Jun 23, 2015
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
QLGN Financial Summary
CIK
0001460702
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
74754R103
ISIN
US74754R2022
Country
US
Price
3.9
Beta
0.14
Volume Avg.
91.89k
Market Cap
2.87M
Shares
-
52-Week
3.336-30.5
DCF
-0.18
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://www.qualigeninc.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest QLGN News
It looks like there's no news available.
